BAL PHARMA LTD.

BALPHARMA

Small Cap | Pharmaceuticals
68.71
-1.61 (-2.28%)

Stock price as on 06 Feb 2026 at 15:27 PM

Bal pharma ltd. share price update

As of the latest trading session, Bal Pharma Ltd. share price is currently at ₹68.71, which is down by ₹-1.61 from its previous closing. Today the sto...

Bal Pharma Ltd. stock performance

Today’s low

₹68.5

Today’s high

₹70.88

₹68.71

52 week low

₹65.7

52 week high

₹128.74

₹68.71
Open
₹69.97
Previous close
₹70.32
Share volume
4,023
Total traded value (Lakh)
₹2.81
Upper circuit
₹84.38
Lower circuit
₹56.26

Bal Pharma Ltd. fundamentals

Market cap (Cr)
₹111.30
P/E ratio (TTM)
14.96
Book value per share
₹62.76
Beta
0.58
Return on equity
8.14%
Earnings per share (TTM)
₹4.65
Dividend yield
1.73%
Net profit/quarter (Cr)
₹0.78

Bal Pharma Ltd. financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹73.75

Operating expense

₹74.11

Net income

₹0.78

Net profit margin

1.05%

Earning per share

₹0.49

EBITDA

₹6.91

Effective tax rate

-

Particulars

Jun 25 (₹ value in crores)

Revenue

₹65.64

Operating expense

₹66.05

Net income

₹0.32

Net profit margin

0.48%

Earning per share

₹0.20

EBITDA

₹6.89

Effective tax rate

-

Particulars

Mar 25 (₹ value in crores)

Revenue

₹81.78

Operating expense

₹79.96

Net income

₹5.61

Net profit margin

6.85%

Earning per share

₹3.51

EBITDA

₹8.82

Effective tax rate

-99.28%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹72.89

Operating expense

₹72.64

Net income

₹0.69

Net profit margin

0.94%

Earning per share

₹0.73

EBITDA

₹8.44

Effective tax rate

6.75%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹74.70

Operating expense

₹73.52

Net income

₹1.20

Net profit margin

1.6%

Earning per share

₹0.76

EBITDA

₹7.81

Effective tax rate

21.05%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹302.50

Operating expense

₹298.92

Net income

₹7.80

Net profit margin

2.57%

Earning per share

₹4.89

EBITDA

₹32.23

Effective tax rate

-36.12%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹338.54

Operating expense

₹331.52

Net income

₹7.73

Net profit margin

2.28%

Earning per share

₹6.72

EBITDA

₹33.83

Effective tax rate

17.06%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹303.10

Operating expense

₹296.73

Net income

₹6.13

Net profit margin

2.02%

Earning per share

₹3.90

EBITDA

₹28.49

Effective tax rate

28.3%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹280.37

Operating expense

₹274.79

Net income

₹8.58

Net profit margin

3.06%

Earning per share

₹5.79

EBITDA

₹29.70

Effective tax rate

28.85%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹249.31

Operating expense

₹242.21

Net income

₹9.10

Net profit margin

3.65%

Earning per share

₹6.41

EBITDA

₹29.02

Effective tax rate

7.14%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹48.63

Return on Equity (ROE)

9.69%

Return on Capital Employed (ROCE)

9.78%

Total debt to equity ratio

1.94

EBITDA margin

10.55%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹45.56

Return on Equity (ROE)

10.97%

Return on Capital Employed (ROCE)

11.29%

Total debt to equity ratio

1.99

EBITDA margin

9.96%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹40.66

Return on Equity (ROE)

4.28%

Return on Capital Employed (ROCE)

9.16%

Total debt to equity ratio

1.92

EBITDA margin

8.61%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹38.92

Return on Equity (ROE)

9.04%

Return on Capital Employed (ROCE)

11.02%

Total debt to equity ratio

1.9

EBITDA margin

9.92%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹35.52

Return on Equity (ROE)

8.89%

Return on Capital Employed (ROCE)

9.32%

Total debt to equity ratio

2.16

EBITDA margin

10.29%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹62.07

Return on Equity (ROE)

8.14%

Return on Capital Employed (ROCE)

9.42%

Total debt to equity ratio

1.45

EBITDA margin

10.72%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹58.74

Return on Equity (ROE)

8.19%

Return on Capital Employed (ROCE)

10.41%

Total debt to equity ratio

1.37

EBITDA margin

10.05%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹61.21

Return on Equity (ROE)

6.69%

Return on Capital Employed (ROCE)

10.08%

Total debt to equity ratio

1.22

EBITDA margin

9.44%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹58.28

Return on Equity (ROE)

9.36%

Return on Capital Employed (ROCE)

11.2%

Total debt to equity ratio

1.21

EBITDA margin

10.22%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹52.88

Return on Equity (ROE)

12.53%

Return on Capital Employed (ROCE)

12.18%

Total debt to equity ratio

1.4

EBITDA margin

11.75%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹8.05

Total assets

₹335.69

Total liabilities

₹335.69

Total equity

₹77.40

Shares outstanding

₹1.59

Price to book ratio

₹1.34

Return on assets (%)

2.14%

Return on capital

3.17%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.29

Total assets

₹319.83

Total liabilities

₹319.83

Total equity

₹71.97

Shares outstanding

₹1.58

Price to book ratio

₹1.55

Return on assets (%)

2.31%

Return on capital

3.49%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹7.61

Total assets

₹313.17

Total liabilities

₹313.17

Total equity

₹63.70

Shares outstanding

₹1.56

Price to book ratio

₹1.09

Return on assets (%)

0.82%

Return on capital

1.32%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹5.39

Total assets

₹260.53

Total liabilities

₹260.53

Total equity

₹58.49

Shares outstanding

₹1.48

Price to book ratio

₹1.85

Return on assets (%)

2.15%

Return on capital

3.59%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹3.85

Total assets

₹240.08

Total liabilities

₹240.08

Total equity

₹53.35

Shares outstanding

₹1.48

Price to book ratio

₹1.02

Return on assets (%)

1.97%

Return on capital

3%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹7.93

Total assets

₹350.56

Total liabilities

₹350.56

Total equity

₹98.82

Shares outstanding

₹1.59

Price to book ratio

₹1.34

Return on assets (%)

2.22%

Return on capital

3.2%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.15

Total assets

₹334.22

Total liabilities

₹334.22

Total equity

₹92.83

Shares outstanding

₹1.58

Price to book ratio

₹1.55

Return on assets (%)

2.31%

Return on capital

3.41%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹7.35

Total assets

₹347.70

Total liabilities

₹347.70

Total equity

₹96.03

Shares outstanding

₹1.56

Price to book ratio

₹1.09

Return on assets (%)

1.76%

Return on capital

2.77%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹5.09

Total assets

₹289.76

Total liabilities

₹289.76

Total equity

₹87.32

Shares outstanding

₹1.48

Price to book ratio

₹1.85

Return on assets (%)

2.96%

Return on capital

4.63%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹3.71

Total assets

₹261.53

Total liabilities

₹261.53

Total equity

₹79.31

Shares outstanding

₹1.48

Price to book ratio

₹1.02

Return on assets (%)

3.47%

Return on capital

4.96%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹5.13

Cash from operations

₹22.39

Cash from investing

-₹14.91

Cash from financing

-₹7.84

Net change in cash

-₹2.44

Free cash flow

₹41.17

Particulars

Mar 24 (₹ value in crores)

Net income

₹9.04

Cash from operations

₹27.34

Cash from investing

-₹18.89

Cash from financing

-₹1.20

Net change in cash

₹2.70

Free cash flow

₹38.32

Particulars

Mar 23 (₹ value in crores)

Net income

₹4.74

Cash from operations

-₹1.03

Cash from investing

-₹22.18

Cash from financing

₹24.09

Net change in cash

₹0.37

Free cash flow

₹13.61

Particulars

Mar 22 (₹ value in crores)

Net income

₹9.18

Cash from operations

₹27.99

Cash from investing

-₹9.48

Cash from financing

-₹17.22

Net change in cash

₹0.08

Free cash flow

₹36.46

Particulars

Mar 21 (₹ value in crores)

Net income

₹4.10

Cash from operations

₹22.44

Cash from investing

-₹5.53

Cash from financing

-₹16.63

Net change in cash

₹0.16

Free cash flow

₹22.44

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹5.73

Cash from operations

₹22.39

Cash from investing

-₹14.90

Cash from financing

-₹7.83

Net change in cash

-₹2.41

Free cash flow

₹41.16

Particulars

Mar 24 (₹ value in crores)

Net income

₹9.31

Cash from operations

₹33.08

Cash from investing

-₹18.84

Cash from financing

-₹6.93

Net change in cash

₹2.76

Free cash flow

₹43.99

Particulars

Mar 23 (₹ value in crores)

Net income

₹8.54

Cash from operations

₹5.87

Cash from investing

-₹22.08

Cash from financing

₹17.12

Net change in cash

₹0.41

Free cash flow

₹20.41

Particulars

Mar 22 (₹ value in crores)

Net income

₹12.05

Cash from operations

₹31.68

Cash from investing

-₹13.43

Cash from financing

-₹17.21

Net change in cash

-₹0.07

Free cash flow

₹39.25

Particulars

Mar 21 (₹ value in crores)

Net income

₹9.79

Cash from operations

₹10.34

Cash from investing

-₹6.65

Cash from financing

-₹3.36

Net change in cash

₹0.21

Free cash flow

₹13.15

Bal Pharma Ltd. technical summary

₹69.93
-0.55 ▼
8
Bearish
8
Bullish
5 Day69.5
10 Day69.3
12 Day69.4
20 Day69.8
26 Day70.3
50 Day72.4
100 Day77.1
200 Day84.8
5 Day69.1
10 Day69
12 Day68.7
20 Day69.6
26 Day70.4
50 Day71.9
100 Day77
200 Day87.1

70.95

PIVOT

First support
₹69.07
First resistance
₹72.19
Second support
₹67.83
Second resistance
₹74.07
Third support
₹65.95
Third resistance
₹75.31
RSI
48.62
ADX
27.23
MACD
-0.92
Williams % R
-42.05
Commodity Channel Index (CCI)
-8.39
Date
06 Feb 2026
Same day
3,731
Week
5,011
Month
5,050
1 year
0.59
3 years
0.75
Over 1 month
-4.19%
Over 1 year
-36.64%
Over 3 months
-12.97%
Over 3 years
-5.22%
Over 6 months
-25.37%
Over 6 years
3.65%

Investment Returns

Over 1 Month4.19%
Over 3 Months12.97%
Over 6 Months25.37%
Over 1 Year36.64%

Bal Pharma Ltd. Shareholding pattern


Public
49%
Promoter holdings
50.85%
FII
0.13%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Shailesh Siroya

27,45,459 (17.24%)

Shareholding of Promoter and Promoter Group

Micro Labs Limited

20,11,736 (12.64%)

Shareholding of Promoter and Promoter Group

Anita Siroya

10,49,220 (6.59%)

Shareholding of Promoter and Promoter Group

Prakash Chandra Jain

5,81,270 (3.65%)

Public Shareholding

Ram Keshav Murthy

5,27,600 (3.31%)

Public Shareholding

Promoter sharesShareCategory
Shailesh Siroya27,45,459 (17.24%)Shareholding of Promoter and Promoter Group
Micro Labs Limited20,11,736 (12.64%)Shareholding of Promoter and Promoter Group
Anita Siroya10,49,220 (6.59%)Shareholding of Promoter and Promoter Group
Prakash Chandra Jain5,81,270 (3.65%)Public Shareholding
Ram Keshav Murthy5,27,600 (3.31%)Public Shareholding
Anand Surana5,25,686 (3.3%)Shareholding of Promoter and Promoter Group
Chandraprakash Dheerajmal Siroya4,86,420 (3.06%)Shareholding of Promoter and Promoter Group
Dilip Surana4,74,994 (2.98%)Shareholding of Promoter and Promoter Group
Naresh D P3,00,207 (1.89%)Public Shareholding
Shreya Mardia3,00,000 (1.88%)Public Shareholding
Asha Tapidas Dodhia2,93,247 (1.84%)Public Shareholding
Archana Surana2,84,996 (1.79%)Shareholding of Promoter and Promoter Group
Gautam Chand Mehta1,89,966 (1.19%)Public Shareholding
Monica Surana1,79,909 (1.13%)Shareholding of Promoter and Promoter Group
Dilip Surana1,69,995 (1.07%)Shareholding of Promoter and Promoter Group
Anita Chandraprakash Siroya1,22,687 (0.77%)Shareholding of Promoter and Promoter Group
Jivi Dheerajmal Siroya46,080 (0.29%)Shareholding of Promoter and Promoter Group

About BAL PHARMA LTD.

Bal Pharma Limited (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 1987. In March 1990, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxic

Parent Organisation

Indian Private

NSE Symbol

BALPHARMA

Founded

1987

BAL PHARMA LTD. CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
18 Sept 20251.2Final18 Sept 2025Equity shares
17 Sept 20241.2Final19 Sept 2024Equity shares
18 Sept 20231Final19 Sept 2023Equity shares
13 Sept 20221Final15 Sept 2022Equity shares
16 Sept 20211Final18 Sept 2021Equity shares
17 Sept 20191Final19 Sept 2019Equity shares
14 Sept 20181Final18 Sept 2018Equity shares
14 Sept 20171Final18 Sept 2017Equity shares
15 Sept 20161Final18 Sept 2016Equity shares
15 Sept 20151Final18 Sept 2015Equity shares
12 Sept 20141Final16 Sept 2014Equity shares
12 Sept 20130.75Final16 Sept 2013Equity shares
17 Sept 20090.75Final22 Sept 2009Equity shares
09 Sept 20081Final11 Sept 2008Equity shares
07 Sept 20070.75Final11 Sept 2007Equity shares
09 Sept 20050Final13 Sept 2005Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)